SCHIMMEL PAUL 4
4 · aTYR PHARMA INC · Filed May 22, 2020
Insider Transaction Report
Form 4
aTYR PHARMA INCLIFE
SCHIMMEL PAUL
Director
Transactions
- Sale
Common Stock
2020-05-20$3.64/sh−8,447$30,739→ 429,143 total(indirect: See Footnote)
Holdings
- 2,890
Common Stock
- 63,023(indirect: See Footnote)
Common Stock
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.605 to $3.72, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F2]There shares are owned directly by Schimmel Revocable Trust U/A Dtd 9/6/2000. The Reporting Person and his spouse are trustees of the Schimmel Revocable Trust U/A Dtd 9/6/2000.
- [F3]These shares are owned directly by Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel. The Reporting Person is the sole owner of the Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel.